The CLSI document M45 provides guidance on the antimicrobial susceptibility testing of bacteria that are not commonly isolated or are fastidious in their growth requirements. These organisms may include those that are rarely encountered in clinical practice or require special media or conditions for growth.
M45 outlines which antimicrobials are clinically relevant. Labs should avoid reporting broad-spectrum cascades unless first-line therapy options are exhausted or contraindicated. Finding and Accessing the CLSI M45 PDF
: Aeromonas spp., Vibrio spp., and Corynebacterium species.
The M45 document includes protocols for a variety of bacteria that are recognized as causes of serious infections but require specific growth conditions. Common examples addressed in the M45 PDF include:
The CLSI M45 document (3rd Edition) provides standardized broth microdilution and disk diffusion susceptibility testing methods for fastidious and infrequently isolated bacteria. It serves as a critical guide for testing pathogens, such as Corynebacterium Campylobacter clsi document m45 pdf
Identifies predictable resistance traits to prevent the reporting of false-susceptible results. Key Organisms Covered in M45
The document outlines three primary testing methodologies depending on the organism: Broth Microdilution
Clinical microbiology laboratories frequently encounter common pathogens like Staphylococcus aureus or Escherichia coli . However, testing infrequently isolated or fastidious bacteria presents a unique challenge. The Clinical and Laboratory Standards Institute (CLSI) addresses this critical gap with the document.
Provides expert-vetted minimum inhibitory concentration (MIC) breakpoints where clinical data is sparse. The CLSI document M45 provides guidance on the
Require fastidious medium; highly susceptible to penicillin but must be monitored for beta-lactamase. Methodology and Technical Implementation
To help provide information tailored to your laboratory workflow, let me know if you are looking for , the differences between the latest and previous editions , or help interpreting a specific drug-microbe combination . Share public link
While less common for rare organisms due to a lack of correlation data, CLSI M45 provides specific disk diffusion criteria for a limited subset of pathogens, such as Campylobacter species. Challenges in Testing Fastidious Organisms
Disclaimer: This guide is a summary. Always refer to the actual, purchased CLSI M45 PDF document for the most current, comprehensive, and legally validated standards. Common examples addressed in the M45 PDF include:
The you currently have available (e.g., manual broth microdilution, gradient strips/Etest)
Which from the M45 guidelines are you currently trying to test? g., broth microdilution vs. disk diffusion)?
You can check the CLSI Breakpoint Implementation Toolkit to ensure your testing methods align with both CLSI and FDA standards.
Formally known as nutritionally variant streptococci.
Intrinsic vancomycin-resistant organisms that can mimic streptococci.
Clinical microbiology laboratories frequently encounter common pathogens like Staphylococcus aureus or Escherichia coli . However, testing rare, fastidious, or unusual microorganisms presents a unique challenge. This is where the Clinical and Laboratory Standards Institute (CLSI) Document M45 becomes indispensable.